Scripta Therapeutics
Biotechnology company developing longevity therapeutics focused on epigenetic reprogramming approaches to treat age-related diseases. Raised $12 million in seed funding in November 2025.
Location
Boston, Massachusetts, USA
Founded
2023
Investors
1
Categories
biotech, therapeutics, longevity, epigenetics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |